617 related articles for article (PubMed ID: 9292394)
61. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
62. Correlation of serum antigen and antibody concentration with clinical features in HIV infection.
Ellaurie M; Rubinstein A
Arch Dis Child; 1991 Feb; 66(2):200-3. PubMed ID: 1705767
[TBL] [Abstract][Full Text] [Related]
63. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
64. Decline in CTL and antibody responses to HIV-1 p17 and p24 antigens in HIV-1-infected hemophiliacs irrespective of disease progression. A 5-year follow-up study.
O'Toole CM; Lowdell MW; Chargelegue D; Colvin BT
AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1361-8. PubMed ID: 1281655
[TBL] [Abstract][Full Text] [Related]
65. More sensitive and simpler immune complex transfer enzyme immunoassay for antithyroglobulin IgG in serum.
Kohno T; Mitsukawa T; Matsukura S; Tsunetoshi Y; Ishikawa E
J Clin Lab Anal; 1989; 3(3):163-8. PubMed ID: 2502610
[TBL] [Abstract][Full Text] [Related]
66. Novel and ultrasensitive noncompetitive enzyme immunoassay (hetero-two-site complex transfer enzyme immunoassay) for alpha-human atrial natriuretic peptide.
Hashida S; Ishikawa E
J Clin Lab Anal; 1992; 6(4):201-8. PubMed ID: 1403340
[TBL] [Abstract][Full Text] [Related]
67. Measurement of anti-thyroglobulin IgG in serum by novel and sensitive immune complex transfer enzyme immunoassay.
Kohno T; Mitsukawa T; Matsukura S; Tsunetoshi Y; Ishikawa E
Clin Biochem; 1989 Aug; 22(4):277-84. PubMed ID: 2673576
[TBL] [Abstract][Full Text] [Related]
68. Combination assay detecting both human immunodeficiency virus (HIV) p24 antigen and anti-HIV antibodies opens a second diagnostic window.
Speers D; Phillips P; Dyer J
J Clin Microbiol; 2005 Oct; 43(10):5397-9. PubMed ID: 16208030
[TBL] [Abstract][Full Text] [Related]
69. Reliable confirmation of antibodies to human immunodeficiency virus type 1 (HIV-1) with an enzyme-linked immunoassay using recombinant antigens derived from the HIV-1 gag, pol, and env genes.
Ng VL; Chiang CS; Debouck C; McGrath MS; Grove TH; Mills J
J Clin Microbiol; 1989 May; 27(5):977-82. PubMed ID: 2787334
[TBL] [Abstract][Full Text] [Related]
70. Detection of one attomole of [Arg8]-vasopressin by novel noncompetitive enzyme immunoassay (hetero-two-site complex transfer enzyme immunoassay).
Hashida S; Tanaka K; Yamamoto N; Uno T; Yamaguchi K; Ishikawa E
J Biochem; 1991 Oct; 110(4):486-92. PubMed ID: 1778973
[TBL] [Abstract][Full Text] [Related]
71. Three antigenic regions in p17 of human immunodeficiency virus type 1 (HIV-1) revealed by mouse monoclonal antibodies and human antibodies in HIV-1 carrier sera.
Liu X; Ota A; Watanabe M; Ueda S; Saitoh A; Shinagawa H; Nakata A; Kurimura T; Wang X; Zhao Y
Microbiol Immunol; 1995; 39(10):775-85. PubMed ID: 8577268
[TBL] [Abstract][Full Text] [Related]
72. IgA immunity in HIV type 1-infected chimpanzees. I. Systemic immunity.
Black KP; Fultz PN; Girard M; Jackson S
AIDS Res Hum Retroviruses; 1997 Oct; 13(15):1263-72. PubMed ID: 9339843
[TBL] [Abstract][Full Text] [Related]
73. HIV-1 neutralizing antibodies in urine from seropositive individuals.
Cao YZ; Friedman-Kien AE; Mirabile M; Li XL; Alam M; Dieterich D; Ho DD
J Acquir Immune Defic Syndr (1988); 1990; 3(3):195-9. PubMed ID: 1968094
[TBL] [Abstract][Full Text] [Related]
74. Urine samples as a possible alternative to serum for human immunodeficiency virus antibody screening.
Martínez P; Lejarazu RO; Eiros JM; Benito JD; Rodríguez-Torres A
Eur J Clin Microbiol Infect Dis; 1996 Oct; 15(10):810-3. PubMed ID: 8950559
[TBL] [Abstract][Full Text] [Related]
75. Reduction of the diagnostic window with a new combined p24 antigen and human immunodeficiency virus antibody screening assay.
Gürtler L; Mühlbacher A; Michl U; Hofmann H; Paggi GG; Bossi V; Thorstensson R; G-Villaescusa R; Eiras A; Hernandez JM; Melchior W; Donie F; Weber B
J Virol Methods; 1998 Nov; 75(1):27-38. PubMed ID: 9820572
[TBL] [Abstract][Full Text] [Related]
76. Performance characteristics of recombinant enzyme immunoassay to detect antibodies to human immunodeficiency virus type 1 (HIV-1) and HIV-2 and to measure early antibody responses in seroconverting patients.
Galli RA; Castriciano S; Fearon M; Major C; Choi KW; Mahony J; Chernesky M
J Clin Microbiol; 1996 Apr; 34(4):999-1002. PubMed ID: 8815130
[TBL] [Abstract][Full Text] [Related]
77. Shortening of the diagnostic window with a new combined HIV p24 antigen and anti-HIV-1/2/O screening test.
Brust S; Duttmann H; Feldner J; Gürtler L; Thorstensson R; Simon F
J Virol Methods; 2000 Nov; 90(2):153-65. PubMed ID: 11064116
[TBL] [Abstract][Full Text] [Related]
78. Detection of anti-HIV-1 IgG antibodies in whole saliva by GACELISA and Western blot assays.
Matee MI; Lyamuya EF; Simon E; Mbena EC; Kagoma C; Samaranayake LP; Scheutz F
East Afr Med J; 1996 May; 73(5):292-4. PubMed ID: 8756029
[TBL] [Abstract][Full Text] [Related]
79. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
80. Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay.
Weber B; Mühlbacher A; Michl U; Paggi G; Bossi V; Sargento C; Camacho R; Fall EH; Berger A; Schmitt U; Melchior W
J Virol Methods; 1999 Mar; 78(1-2):61-70. PubMed ID: 10204697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
